Bank of America Corp DE Takes Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Bank of America acquired 731,656 shares of Acadia Healthcare in the second quarter, valued at approximately $21.6 million and representing a 0.79% stake.
• Acadia Healthcare reported quarterly EPS of $0.38, beating estimates of $0.35, while revenue of $865.8 million exceeded expectations but declined 0.4% year over year.
• Shares opened at $28.51 after falling 2.9%; analysts maintain a consensus “Hold” rating with an average price target of $30.69, despite several firms raising their targets.

Bank of America Corp DE bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 731,656 shares of the company's stock, valued at approximately $21,606,000. Bank of America Corp DE owned 0.79% of Acadia Healthcare at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Allworth Financial LP purchased a new position in shares of Acadia Healthcare during the 2nd quarter valued at about $45,000. Global Retirement Partners LLC purchased a new stake in shares of Acadia Healthcare in the second quarter worth about $68,000. Quantbot Technologies LP acquired a new stake in Acadia Healthcare during the second quarter worth about $88,000. Teachers Retirement System of The State of Kentucky lifted its holdings in Acadia Healthcare by 5.1% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 75,095 shares of the company's stock valued at $1,757,000 after acquiring an additional 3,642 shares during the period. Finally, PNC Financial Services Group Inc. lifted its holdings in Acadia Healthcare by 103.5% in the first quarter. PNC Financial Services Group Inc. now owns 7,234 shares of the company's stock valued at $169,000 after acquiring an additional 3,680 shares during the period.

Acadia Healthcare Stock Down 2.9%

Shares of NASDAQ ACHC opened at $28.51 on Thursday. The stock has a market cap of $2.65 billion, a PE ratio of -2.29, a P/E/G ratio of 9.46 and a beta of 0.62. The company has a 50-day moving average of $29.99 and a 200 day moving average of $27.32. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million during the quarter, compared to analysts' expectations of $844.19 million. During the same quarter last year, the firm earned $0.83 earnings per share. The business's revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Barclays lifted their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an "equal weight" rating in a report on Thursday, July 30th. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. TD Cowen raised their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. Leerink Partners boosted their price objective on Acadia Healthcare from $30.00 to $33.00 and gave the company a "market perform" rating in a research report on Wednesday. Finally, UBS Group lifted their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $30.69.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia's facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.